Desirudin Subcutaneous and Moxetumomab Pasudotox-tdfk
Determining the interaction of Desirudin Subcutaneous and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: desirudin
Brand name: Iprivask
Synonyms: Desirudin
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Desirudin Subcutaneous-Moxetumomab pasudotox-tdfk Intravenous
- Desirudin Subcutaneous-Moxifloxacin
- Desirudin Subcutaneous-Moxifloxacin (Systemic)
- Desirudin Subcutaneous-Moxifloxacin Hydrochloride
- Desirudin Subcutaneous-Moxifloxacin Injection
- Desirudin Subcutaneous-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Desloratadine
- Moxetumomab Pasudotox-tdfk-Desloratadine and pseudoephedrine
- Moxetumomab Pasudotox-tdfk-Desloratadine Oral Solution
- Moxetumomab Pasudotox-tdfk-Desloratadine Orally Disintegrating Tablets
- Moxetumomab Pasudotox-tdfk-Desloratadine Syrup
- Moxetumomab Pasudotox-tdfk-Desloratadine Tablets